Leadership & Team
A lean, high-calibre founding team with deep expertise in proteomics, oncology clinical development, regulatory affairs, and biomarker commercialisation — assembled to execute Synoptic's seed-stage programme.
CW
CW
Founded and directed the Pharma Proteomics Project — a 13-company pre-competitive consortium producing one of the world's largest plasma proteomics datasets (3,000 proteins · 54,000 samples), with primary findings published in Nature.
- Head of Molecular Neuroscience & Data Science, Johnson & Johnson
- Head of Translational Genetics, Biogen
- Neuroscience Genetics Lead, Pfizer
- Founded ENIGMA-Epilepsy imaging consortium
- Strategic advisor to Eli Lilly, Danaher, and AbbVie on proteomics
- Ph.D., Royal College of Surgeons in Ireland · Postdoc, USC
SA
Translational scientist with deep expertise in multi-omics, plasma proteomics, and biomarker discovery — skill set directly matched to Synoptic's platform and programme.
- Lab Head, Alkahest, Inc. — plasma proteomics & ageing biology
- Multi-omics integration: proteomics, genomics, and metabolomics
- Human cohort biomarker discovery in translational disease settings
EM
Commercial and business development leader with 15+ years across protein biomarker discovery tools — bringing established relationships with pharma, diagnostics, and research partners.
- VP Commercial, Thermo Fisher Scientific (current)
- 15+ years in protein biomarker tools and commercial strategy
- Deep network across pharma proteomics, IVD, and research markets
DM
Oncology clinical development leader spanning major pharma and the cutting edge of liquid biopsy diagnostics — bringing exactly the clinical trial design and regulatory pathway expertise Synoptic requires.
- VP Clinical Development, DELFI Diagnostics (recently departed)
- Global Head of Clinical Development, Roche Oncology & Genetics
- Deep experience in IVD clinical development and regulatory strategy
EL
20+ years of hands-on regulatory expertise across IVDs and medical devices. As founder of EL Regulatory, brings independent practice depth across 510(k), De Novo, and global IVD pathways.
- Founder, EL Regulatory — IVD & medical device regulatory consultancy
- 20+ years in IVD regulation, 510(k) and De Novo submissions
- Global IVD regulatory strategy and EU IVDR experience
TV
Seasoned informatics and scientific project/operations manager with a rare combination of bioinformatics credentials and hands-on delivery leadership. Recent experience includes leading informatics projects at Intellia Therapeutics for the Genomic Operations team (2.5 years). Prior to that, three years at the Broad Institute across genomics and informatics project management.
- Sr. Project Manager – Informatics, Intellia Therapeutics (2.5 yrs) — Genomic Operations team
- Project Manager – Informatics, Broad Institute — clinical sample intake infrastructure, SmartSheet rollup systems, and CCDG genomics data delivery
- MS Bioinformatics, Northeastern University (GPA 4.0) · Licensed Scrum Master
The following roles are planned for hire following seed funding, as the proteomics discovery programme scales and data generation accelerates under Sara Ahadi's scientific leadership.